NVIDIA
NVDA
Meta Platforms
META
Oracle
ORCL
Amazon
AMZN
Strategy
MSTR
US Stock MarketDetailed Quotes
DCTH Delcath Systems
- 14.690
- +0.440+3.09%
Trading Feb 26 13:31 ET
531.78MMarket Cap-12.56P/E (TTM)
14.970High14.261Low78.56KVolume14.300Open14.250Pre Close1.16MTurnover0.23%Turnover RatioLossP/E (Static)36.20MShares16.43052wk High61.98P/B496.96MFloat Cap2.25052wk Low--Dividend TTM33.83MShs Float7069.999Historical High--Div YieldTTM4.98%Amplitude-9223372036.855Historical Low14.754Avg Price1Lot Size
About Delcath Systems Company
Delcath Systems, Inc. is an oncology company, which engages in the treatment of primary and metastatic liver cancers. Its products include CHEMOSAT and HEPZATO. The company was founded in August 1988 and is headquartered in Queensbury, NY.
Company Profile
SymbolDCTH
Company NameDelcath Systems
Issue Price10.00
Founded1988
CEOMr. Gerard J. Michel
MarketNASDAQ
Employees76
Fiscal Year Ends12-31
Address566 Queensbury Avenue
CityQueensbury
ProvinceNew York
CountryUnited States of America
Zip Code12804
Phone1-212-489-2100
Websitehttp://www.delcath.com
Company Executives
- Name
- Position
- Salary
- Gerard J. Michel
- Interim Principal Accounting Officer, Director, President and Chief Executive Officer
- 2.52M
- David L. Hoffman
- General Counsel, Chief Compliance Officer and Corporate Secretary
- --
- Dr. Martha S. Rook, PhD
- Chief Operating Officer
- --
- Kevin Muir
- General Manager, Interventional Oncology
- 1.02M
- Sandra Pennell
- Senior Vice President, Finance
- --
- Dr. Johnny John, M.D.
- Senior Vice President, Clinical Development and Medical Affairs
- --
- John Richard Sylvester
- Chairman of the Board
- 204.88K
- Elizabeth A. Czerepak
- Independent Director
- 188.51K
- Steven Salamon
- Independent Director
- 183.96K
- Dr. Gilad Aharon, PhD
- Independent Director
- 172.96K
- Dr. Roger G. Stoll,PhD
- Independent Director
- 188.48K
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.